EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Menke–Hennekam Syndrome as a Domain-Resolved Disorder of the Transcriptional Coactivators CBP and p300

Despina Sanoudou iD, Anna Maria Anastasiou, Aristides G Eliopoulos iD

Genes · 2026

DOI: 10.3390/genes17101285 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2026. Verfasst von Despina Sanoudou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Genomics and Pharmacogenomics Unit, and Genetic and Pharmacogenetic Counseling Clinic, 4th Department of Internal Medicine, School of Medici…. Hauptthemen laut MEDLINE: E1A-Associated p300 Protein, CREB-Binding Protein. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menke–Hennekam syndrome (MKHK) is a rare neurodevelopmental disorder caused by pathogenic variants in discrete regions of the transcriptional coactivators CBP and p300, encoded by CREBBP and EP300. Recent genotype–phenotype and DNA methylation studies support a domain-resolved classification involving their ZZ, TAZ2 and ID4 regions and distinguish MKHK from classical Rubinstein–Taybi syndrome. Here, we review the genetic and clinical architecture of MKHK, the regulatory functions of the affected CBP/p300 domains and the emerging epigenomic taxonomy of the disorder. We discuss emerging evidence that localized variants may alter specific protein interactions, chromatin engagement or inter-domain regulation rather than uniformly reducing coactivator activity. On this basis, we propose domain-selective transcriptional rewiring as a testable framework for MKHK pathogenesis. We further consider experimental models required to establish causal mechanisms and implications for therapeutic development. MKHK provides an informative example of how pathogenic variants in multidomain regulatory proteins can produce domain-specific developmental disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

E1A-Associated p300 ProteinCREB-Binding ProteinHumansRubinstein-Taybi SyndromeAnimalsProtein Domains

Stichwörter der Autor:innen

CBP/p300CREBBPDNA methylationEP300Menke–Hennekam syndromechromatinopathyepisignaturegeneticsiPSCneurodevelopmentorganoidstranscriptional rewiring

Substanzen

E1A-Associated p300 ProteinEP300 protein, humanCREB-Binding ProteinCREBBP protein, human

Autor:innen und Institutionen

  • Clinical Genomics and Pharmacogenomics Unit, and Genetic and Pharmacogenetic Counseling Clinic, 4th Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Gree…
  • Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
  • Molecular Genetics Unit, Department of Biology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Institute of Molecular Biology and Biotechnology, Foundation for Research & Technology-Hellas, 71003 Heraklion, Greece.

ORCID-Profile: Despina Sanoudou, Aristides G Eliopoulos

Zitieren

APA

Sanoudou, D., Anastasiou, A. M., & Eliopoulos, A. G. (2026). Menke–Hennekam Syndrome as a Domain-Resolved Disorder of the Transcriptional Coactivators CBP and p300. Genes. https://doi.org/10.3390/genes17101285

Vancouver

Sanoudou D, Anastasiou AM, Eliopoulos AG. Menke–Hennekam Syndrome as a Domain-Resolved Disorder of the Transcriptional Coactivators CBP and p300. Genes. 2026. doi:10.3390/genes17101285

BibTeX
@article{Sanoudou2026,
  author = {Sanoudou, Despina and Anastasiou, Anna Maria and Eliopoulos, Aristides G},
  title = {Menke–Hennekam Syndrome as a Domain-Resolved Disorder of the Transcriptional Coactivators CBP and p300},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17101285}
}
Kostenlos starten →